Hvivo Plc (HVO) Ord 0.1p
0.80p
(3.62%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.80p
(3.62%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.80p
(3.62%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Business summary
hVIVO plc is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. It operates through medical and scientific research services segment. It provides end-to-end early clinical development services to its client base, which includes global biopharma companies. It offers a portfolio of approximately 11+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services. It offers additional clinical field trial services, such as Challenge Models, Pre-clinical, CMC & PK, Study Design & Protocol Development, Ethics & Regulatory, Phase I & II, Volunteer/Patient Recruitment, Clinical site, Monitoring, Biometrics, and Medical Writing. Its subsidiaries include hVIVO Holdings Limited, Open Orphan DAC, hVIVO Inc., and others.
Contact details
Important dates
General stock information
- EPIC:
- HVO
- ISIN:
- GB00B9275X97
- Market cap:
- £155.81 million
- Shares in issue:
- 680.37 million
- Sector:
- Health Care Equipment & Services
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- FTSE AIM 100,FTSE AIM All Share
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.